Stroke Genomics

Methods and Reviews, Methods in Molecular Medicine 104

106,99 €
(inkl. MwSt.)
In den Warenkorb

Lieferbar innerhalb 1 - 2 Wochen

Bibliografische Daten
ISBN/EAN: 9781617375002
Sprache: Englisch
Umfang: x, 351 S., 65 s/w Illustr., 351 p. 65 illus.
Auflage: 1. Auflage 2005
Einband: kartoniertes Buch

Beschreibung

InhaltsangabePart I. Introduction Introduction to Stroke Genomics Simon J. Read and Frank C. Barone Part II. Preclinical Models and Gene Manipulation Choice, Methodology, and Characterization of Focal Ischemic Stroke Models: The Search for Clinical Relevance David Virley Mutant Animal Models of Stroke and Gene Expression: The Stroke-Prone Spontaneously Hypertensive Rat Hilary V. O. Carswell, Martin W. McBride, Delyth Graham, Anna F. Dominiczak, and I. Mhairi Macrae Gene Therapy in Neurological Disease Midori A. Yenari and Robert M. Sapolsky Stem Cell Transplantation After Middle Cerebral Artery Occlusion Paul Stroemer and Helen Hodges Endogenous Brain Protection: Models, Gene Expression, and Mechanisms Frank C. Barone Production of Transgenic and Mutant Mouse Models Alex J. Harper 3Nitropropionic Acid Model of Metabolic Stress: Assessment by Magnetic Resonance Imaging Toby John Roberts Part III. Clinical Paradigms Practicalities of Genetic Studies in Human Stroke Ahamad Hassan and Hugh S. Markus Evaluation of the Interactions of Common Genetic Mutations in Stroke Zoltán Szolnoki Part IV. Assessing Differential Expression Technologies of Disease-Related Gene Discovery Using Preclinical Models of Stroke Xinkang Wang Quantitative Analysis of Gene Transcription in Stroke Models Using Real-Time RT-PCR David C. Harrison and Brian C. Bond Effective Analysis of Genomic Data Paul R. Nelson, Andrew B. Goulter, and Richard J. Davis Bioinformatic Approaches to Assigning Protein Function From Novel Sequence Data David Michalovich and Richard Fagan Pragmatic Target Discovery From Novel Gene to Functionally Defined Drug Target: The Interleukin-1 Story Stuart McRae Allan Indexf

Inhalt

Part I. Introduction Introduction to Stroke Genomics Simon J. Read and Frank C. Barone Part II. Preclinical Models and Gene Manipulation Choice, Methodology, and Characterization of Focal Ischemic Stroke Models: The Search for Clinical Relevance David Virley Mutant Animal Models of Stroke and Gene Expression: The Stroke-Prone Spontaneously Hypertensive Rat Hilary V. O. Carswell, Martin W. McBride, Delyth Graham, Anna F. Dominiczak, and I. Mhairi Macrae Gene Therapy in Neurological Disease Midori A. Yenari and Robert M. Sapolsky Stem Cell Transplantation After Middle Cerebral Artery Occlusion Paul Stroemer and Helen Hodges Endogenous Brain Protection: Models, Gene Expression, and Mechanisms Frank C. Barone Production of Transgenic and Mutant Mouse Models Alex J. Harper 3-Nitropropionic Acid Model of Metabolic Stress: Assessment by Magnetic Resonance Imaging Toby John Roberts Part III. Clinical Paradigms Practicalities of Genetic Studies in Human Stroke Ahamad Hassan and Hugh S. Markus Evaluation of the Interactions of Common Genetic Mutations in Stroke Zoltan Szolnoki Part IV. Assessing Differential Expression Technologies of Disease-Related Gene Discovery Using Preclinical Models of Stroke Xinkang Wang Quantitative Analysis of Gene Transcription in Stroke Models Using Real-Time RT-PCR David C. Harrison and Brian C. Bond Effective Analysis of Genomic Data Paul R. Nelson, Andrew B. Goulter, and Richard J. Davis Bioinformatic Approaches to Assigning Protein Function From Novel Sequence Data David Michalovich and Richard Fagan Pragmatic Target Discovery From Novel Gene to Functionally Defined Drug Target: The Interleukin-1 Story Stuart McRae Allan IndexÆ''

Schlagzeile

Cutting-Edge Reviews of the Clinical and Preclinical Genomics of Stroke>